About Olon USA
Who we are: On June 9, 2017, Olon S.p.A., a leading Active Pharmaceutical Ingredients (API) contract development and manufacturing organization (CDMO) and Generics supplier, announced the acquisition of Ricerca Biosciences’ Chemical Division of the contract research (CRO) and CDMO based in Concord, Ohio, USA. This acquisition strengthens the service offering of Olon for the pharmaceutical and biotech industry and benefits Ricerca Biosciences' customer base by providing large-scale manufacturing capabilities in Europe. Olon Ricerca Bioscience is a US-based CRO supporting the development and manufacture of APIs and performance materials in support clinical supply, market development and commercial distribution. Olon Ricerca’s extensive process/synthetic chemistry, analytical chemistry and engineering expertise provides a synergy that excels at first-time scale-ups and subsequent development of safe, reliable, robust and cost-effective manufacturing processes. For more than 25 years, Olon Ricerca has a record of on-time delivery and quality, providing comprehensive support and problem solving for successful development, scale-up and process-optimized manufacture of pharmaceutical ingredients. Company Details Website: http://www.olonricerca.com Location: Concord, OH
Leadership at Olon USA
The team at the top of the org chart.
Luca Caironi
Chairman
25 reports
James Szabo
Vice President and Senior Research Fellow, Pathology and Drug Safety
Kyle P. Kalbarczyk
VP of Operations and Development
1 report
Lisa Mothersbaugh
Director of Finance And Human Resources
1 report
Jeremy Miller
Director of Process Development & Manufacturing
8 reports
Brent Saba
Director, Business Development
Ed White
Director of Quality
7 reports
Nerissa Chu-A-Kong
Director of Business Development
Johnny Chapman III
Director of Business Development